A randomized, open-label, multicentre, parallel-controlled study comparing the efficacy and safety of biphasic insulin aspart 30 plus metformin with biphasic insulin aspart 30 monotherapy for type 2 diabetes patients inadequately controlled with oral anti
Guo, Lixin, Chen, Li, Chang, Baocheng, Yang, Liyong, Liu, Yu, Feng, BoLanguage:
english
Journal:
Diabetes, Obesity and Metabolism
DOI:
10.1111/dom.13454
Date:
July, 2018
File:
PDF, 1.22 MB
english, 2018